RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

I took a quick look at the roster of all forty (ten per therapeutic area) companies that were on the Windhover 'Top 10'
lists last November. I didnt go and check each company on the non-neuro lists, but to the degree my recognition memory still functions, I don't believe any of them have signed a partnership in the ensuing (almost) four months.

Whether this represents an overall shift in strategy amongst Big Pharma is questionable. As I posted before, there was a period of 2-3 months this (almost) past winter where everyone seemed pretty paralyzed. Unless a deal had already been nearly completed, everyone was afraid to spend in such a chaotic environment. I saw a 50-60% decrease in revenues, a BP consulting contract suddenly vaporize, it was a nuclear winter for a while. I am extending credit to some microcaps who can't pay their bills, ironically enough.

There has been some thawing of late, as if pharma has realized life must, and will, go on. But this simply means stasis has transformed back into Pharma's usual glacial pace.

NeuroInvestment